Literature DB >> 11750970

Human chorionic gonadotropin patterns after a single dose of methotrexate for ectopic pregnancy.

Andrea Natale1, Mauro Busacca, Massimo Candiani, Luciano Gruft, Stefano Izzo, Irene Felicetta, Mario Vignali.   

Abstract

OBJECTIVE: The great variability in human chorionic gonadotropin (HCG) levels after a single dose of methotrexate (MTX) for ectopic pregnancy makes it difficult to predict treatment failure. We describe different patterns of HCG levels. STUDY
DESIGN: Fifty patients were injected i.m. with 50mg/m(2) of MTX for an ectopic pregnancy. Venous blood samples for HCG detection were obtained on the day of treatment (day 0), day 3 and day 7 and weekly until values were undetectable. Patients were classified as: group 1, persistent pathology (n=11); group 2, complete resolution with a decrease of HCG levels at day 3 (n=30); group 3, complete resolution after a rise of HCG values at day 3 (n=9). Statistical analysis was performed using the Mann-Whitney non-parametric test with 95% confidence intervals.
RESULTS: Values of day 0 were similar for all the groups. HCG levels of group 3 decreased rapidly after day 3 and at day 7 they were significantly different from levels of group 1. Differences in HCG levels between groups 2 and 3 became indistinguishable from day 21.
CONCLUSION: The observation of patients undergoing resolution after an initial increase of HCG levels justify an expectant management for 1 week in clinically stable patients. The strategy to separate HCG curves in patients undergoing resolution may shed light on the different clinical responses to therapy for ectopic pregnancies. However, the phenomenon of the immediate rise of HCG should be better investigated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11750970     DOI: 10.1016/s0301-2115(01)00480-8

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  6 in total

1.  Time to resolution of tubal ectopic pregnancy following methotrexate treatment: A retrospective cohort study.

Authors:  Marcus J Davenport; Anthea Lindquist; Fiona Brownfoot; Natasha Pritchard; Stephen Tong; Roxanne Hastie
Journal:  PLoS One       Date:  2022-05-24       Impact factor: 3.752

2.  Interstitial pregnancy treated with a single-dose of systemic methotrexate: A successful management.

Authors:  Serena Corioni; Federica Perelli; Claudia Bianchi; Mauro Cozzolino; Luana Maggio; Giulia Masini; Maria Elisabetta Coccia
Journal:  J Res Med Sci       Date:  2015-03       Impact factor: 1.852

3.  The Use of Beta-Human Chorionic Gonadotropin (β-hCG) Levels as a Predictor of Successful Medical Management of Ectopic Pregnancy.

Authors:  Ahmed S Keshta; Dalal Alarabi; Rafiea Jeddy; Maryam M Almusalam; Noor Albastaki; Aysha Alsadoon; Warda Mustafa; Haya Albuainain; Nayla Bushaqer; Nawal M Dayoub
Journal:  Cureus       Date:  2022-02-14

4.  Predictors of success of repeated injections of single-dose methotrexate regimen for tubal ectopic pregnancy.

Authors:  Geum Joon Cho; Sang Hoon Lee; Jin Woo Shin; Nak Woo Lee; Tak Kim; Hai Joong Kim; Kyu Wan Lee
Journal:  J Korean Med Sci       Date:  2006-02       Impact factor: 2.153

5.  Comparison of Four Methods of Treating Ectopic Pregnancy: A Retrospective Cohort Study.

Authors:  Zeynep Ozturk Inal; Hasan Ali Inal
Journal:  Geburtshilfe Frauenheilkd       Date:  2018-01-22       Impact factor: 2.915

6.  Predictors and clinical features of methotrexate (MTX) therapy for ectopic pregnancy.

Authors:  Jing Zhang; Yu Zhang; Lu Gan; Xiao-Ying Liu; Shan-Ping Du
Journal:  BMC Pregnancy Childbirth       Date:  2020-10-29       Impact factor: 3.007

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.